Job Information
- Organisation/Company: University of Gdansk
- Department: International Centre for Cancer Vaccine Science
- Research Field: Technology » Biotechnology
- Researcher Profile: Recognised Researcher (R2)
- Positions: Postdoc Positions
- Application Deadline: 20 Sep 2026 - 23:59 (Europe/Warsaw)
- Country: Poland
- Type of Contract: Temporary
- Job Status: Full-time
- Hours Per Week: 40
- Offer Starting Date: 1 Nov 2026
- Is the job funded through the EU Research Framework Programme? Other EU programme
Offer Description
We are looking for a Post-doctoral Researcher to work in the International Centre for Cancer Vaccine Science (ICCVS) hosted by the University of Gdańsk. The position is offered in the Cancer Immunology research group led by prof. Natalia Marek-Trzonkowska.
The position is offered in the frame of the project No. FENG.02.01-IP.05-0031/23 "Science for Welfare, Innovations, and Forceful Therapies (SWIFT)". The project is implemented under the International Research Agenda program financed by the European Funds for a Smart Economy 2021-2027 (FENG), Priority FENG.02 Innovation-friendly environment, Measure FENG.02.01 International Research Agendas.
About the SWIFT project
ICCVS is the Center of Excellence established in 2017 as part of the IRAP programme of FNP at the University of Gdańsk. Since then, we have elaborated an algorithm for identification of cancer specific T cells, which selectively kill autologous tumour but not healthy lung tissue. Simultaneously, we have developed the method for identification and quantification of cancer specific antigens (neoantigens) presented by MHC class I molecules of the tumour. Therefore, in the current project we want to use this experience and know-how to develop comprehensive anti-cancer therapy that will be translated into clinical trial and will open new research pathways in oncology. To achieve this goal the current project is composed of the following 2 parts which will be developed in parallel: 1). Clinical Trial and 2) Research and Development Activities focused on improvement of the approach tested in clinical trial. With the SWIFT project we aim to stream R&D activity into the following directions: 1). Identification of neoantigens presented by the tumour MHC class I and class II molecules and isolation of T cell clones that recognize them (groups involved: Clinical Peptidomics, Cancer Immunology, Structural Peptidomics and Immune Memory & Cell Reprogramming) 2). Determination of specific receptor-ligand pairs responsible for docking of cancer derived extracellular vesicles (EVs) to T cells (groups involved: Clinical Peptidomics, Structural Proteomics and Cancer Immunology) 3). Development of the strategies preventing T cell reprogramming by cancer derived EVs (groups involved: Immune Memory & Cell Reprogramming, Structural Proteomics and Cancer Immunology) 4). Modification of tumour microenvironment with reprogrammed autologous monocytes (groups involved: Immune Memory & Cell Reprogramming, Cancer Immunology, Structural Proteomics and Clinical Peptidomics).
About ICCVS
The International Centre for Cancer Vaccine Science (ICCVS) has been established in 2017 as a joint unit of the University of Gdańsk (UG) and the University of Edinburgh (UoE) within a project carried out within the International Research Agendas Programme of the Foundation for Polish Science funded from the European Regional Development Fund. The aim of ICCVS has been comprehensive research into development of novel diagnostic and prognostic markers and personalized anti-cancer therapies and vaccines, followed by their commercialization and implementation into clinical practice. ICCVS works on a range of national and international research projects concentrating on cancer biology and novel approaches to immunotherapies. The focus of the ICCVS is the development of personalized vaccine against non-small cell lung cancer (NSCLC). The approach is based on use of cancer specific T cells that are selected by the special algorithm elaborated at ICCVS. The first in vitro and in vivo studies are very encouraging, and the team plans to start clinical trials in a few years.
More information you can find here: www.iccvs.ug.edu.pl
Where to apply
E-mail: iccvs@ug.edu.pl
Requirements
Research Field: Technology » Biotechnology
Education Level: PhD or equivalent
Skills/Qualifications
- PhD degree in biotechnology, biology, medical science or other fields related to cancer biology (PhD degree obtained no earlier than 2022).
- Required skills: experience in cell culture (especially in the culture of human T cells); experience in the biobanking (especially cells); extensive experience in working with a flow cytometer and cell sorter (ability to independently perform compensation and data analysis, as well as hands-on experience in operating this equipment); experience in working with spectral flow cytometry is an asset; experience in isolating cancer cells and establishing primary cultures; experience in working with extracellular vesicles/exosomes and research techniques requiring the use of an ultracentrifuge is an asset; experience in working in a laboratory that meets GMP (Good Manufacturing Practice) standards is an asset; Very good written, oral communication and presentation skills.
- Good knowledge of English (written and spoken).
- Commitment to working collaboratively within an inclusive and diverse multicultural environment.
- Research experience abroad or in an international team will be an asset.
- National/International grants/funding writing experience will be an asset.
Specific Requirements
- Actively conducting scientific research according to the project’s research agenda.
- Presentation and discussion of research progress and scientific results at ICCVS and at external events.
- Participation in training, protocol development, seminars, group meetings, and other activities of scientific exchange indispensable for the progress of the project.
- Analysis and interpretation of research results.
- Writing of scientific publication.
Languages: ENGLISH
Level: Good
Additional Information
Benefits
- Full-time employment at the International Centre for Cancer Vaccine Science at the University of Gdansk. The start date of employment is as soon as possible but negotiable.
- Academic and organizational support.
- Fully operational research equipment and specialist laboratory facilities.
- Friendly, inspiring, interdisciplinary environment.
- Additional yearly remuneration (so-called “13th salary”), if eligible and according to binding provisions at the University
- Holiday allowance/ Christmas allowance, if eligible and according to binding provisions at the University
- Possibility of paid participation in private medical insurance, Multisport offer, life insurance.
- Possibility of use of the Universities holiday facilities.
- Possibility to apply for university accommodation.
- Excellent opportunities for professional development, such as participation in training courses and scientific conferences in Poland and abroad.
- Excellent location in Gdańsk-Śródmieście district.
Eligibility criteria
- Curriculum vitae with a list of publications (if any), and a list of ongoing research projects (with specification of role in the research if unclear); a list of conference talks (if any), and a list of training (if any); a list of academic prizes and awards (if any);
- PDF files of (at most) three relevant papers by the candidate (or web links, in the case of open access publications);
- Motivation letter (including statement of current scientific interests) – up to 2 pages;
- Signed statement on the GDPR information clause for this job offer according to the template provided here https://iccvs.ug.edu.pl/wp-content/uploads/2026/08/Job_offer_2026_03.pdf.
- Documents confirming academic degrees (a scan of doctoral diploma or document certifying that the title has been granted or a declaration about the planned date of defense which should not be later than 3 months from the date of announcement of this job offer) NOTE: Before signing the employment contract, the person selected in the competition is requested to submit to the University of Gdansk the original of the PhD diploma.
- References: contact details (name, affiliation, email) of two senior researchers who can be contacted for references. Please prepare documents referring to items 1-4 in English and merge to ONE pdf file.
Selection process
- The decision will be made by the Recruitment Committee (RC) no later than 3 months from the deadline for submission of applications.
- An interview will be held (online or onsite). The interview is planned for late September.
- The RC reserves the right to invite only pre-selected candidates for the interview.
- The RC’s decision is final and is not subject to appeal.
- The RC reserves the right to close the competition without selecting a candidate.
- In the event of resignation from accepting the position of the selected candidate, the RC has the right to send the offer to a person placed on the reserve list, and in the absence of such a list, the RC has the right to reconsider the applications submitted to the competition and to select another candidate.
Additional comments
Submit the documents at iccvs@ug.edu.pl. Please add in the subject of the email the reference: “post-doc 2026_03”.
Website for additional job details: https://iccvs.ug.edu.pl/wp-content/uploads/2026/08/Job_offer_2026_03.pdf
Work Location(s)
Number of offers available: 1
Company/Institute: International Centre for Cancer Vaccine Science, University of Gdansk
Country: Poland
State/Province: pomorskie
City: Gdańsk
Postal Code: 80-809
Street: Kładki 24
Geofield
Contact
State/Province: pomorskie
City: Gdańsk
Website: http://www.iccvs.ug.edu.pl/
Street: prof. Marii Janion 7
Postal Code: 80-309
E-Mail: iccvs@ug.edu.pl
This is a Preview Listing…
You must sign in to see the full job description, and to apply.
Manage / Upgrade this job to a Full Job Listing.
Find Your Best Opportunity
Tell them AcademicJobs.com sent you!
